Phase II trial of GVDexa (gemcitabine, vinorelbine and dexamethasone) regimen in relapsed/refractory Hodgkin's lymphoma.

被引：0
|
作者：
Mehra, Nikita
Ganesan, Prasanth
Jayachandran, P. K.
Joel, Anjana
Karunakaran, Parathan
Radhakrishnan, Venkatraman
Ganesan, Trivadi S.
Rathinam, Krishna
Gnana, Sagar Tenali
机构：
[1] Canc Inst WIA, Chennai, Tamil Nadu, India
[2] Jawaharlal Inst Postgrad Med Educ & Res, Pondicherry, India
[3] Christian Med Coll, Vellore, Tamil Nadu, India
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e19519
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19519
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Bendamustine in Combination with Gemcitabine and Vinorelbine (BEGEV) is an Effective Regimen for Heavily Pretreated, Relapsed or Refractory Hodgkin Lymphoma Patients: A Retrospective Study
    Russo, Antonio
    Ricci, Francesca
    Magagnoli, Massimo
    Rodari, Marcello
    Morello, Lucia
    Mazza, Rita
    Chiti, Arturo
    Castagna, Luca
    Santoro, Armando
    Carlo-Stella, Carmelo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S234 - S234
  • [42] IFOSFAMIDE, GEMCITABINE AND VINORELBINE (IGEV) IS AN EFFECTIVE SALVAGE REGIMEN WITH EXCELLENT STEM CELL MOBILIZATION IN RELAPSED AND REFRACTORY PEDIATRIC HODGKIN LYMPHOMA
    Marr, Kristin
    Nadel, Helen
    Strahlendorf, Caron
    Davis, Jeffrey
    Deyell, Rebecca
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S15 - S15
  • [43] Combination chemotherapy with gemcitabine and vinorelbine in the treatment of relapsed or refractory Diffuse Large B-cell Lymphoma. A phase II trial by the Hellenic Cooperative Oncology Group (HECOG).
    Papageorgiou, E
    Tsirigotis, P
    Dimopoulos, M
    Pavlidis, N
    Foutzilas, G
    Papageorgiou, S
    Economopoulos, T
    ANNALS OF ONCOLOGY, 2005, 16 : 220 - 220
  • [44] Results of a phase II multicenter trial of single-agent gemcitabine in patients with relapsed or chemotherapy-refractory Hodgkin's lymphoma
    Venkatesh, H
    Di Bella, N
    Flynn, TP
    Vellek, MJ
    Boehm, KA
    Asmar, L
    CLINICAL LYMPHOMA, 2004, 5 (02): : 110 - 115
  • [45] Gemcitabine, vinorelbine and prednisone for refractory or relapsed aggressive lymphoma,results of a phase II single center study
    Müller-Beissenhirtz, H
    Kasper, C
    Nückel, H
    Dührsen, U
    ANNALS OF HEMATOLOGY, 2005, 84 (12) : 796 - 801
  • [46] Gemcitabine, vinorelbine and prednisone for refractory or relapsed aggressive lymphoma,results of a phase II single center study
    Hannes Müller-Beißenhirtz
    Christoph Kasper
    Holger Nückel
    Ulrich Dührsen
    Annals of Hematology, 2005, 84 : 796 - 801
  • [47] Ifosfamide and vinorelbine: an active regimen for patients with relapsed or refractory Hodgkin's disease
    Bonfante, V
    Viviani, S
    Santoro, A
    Devizzi, L
    Di Russo, A
    Zanini, M
    Soncini, F
    Parra, HS
    Valagussa, P
    Bonadonna, G
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 103 (02) : 533 - 535
  • [48] A phase II trial of Rituximab plus ESHAP as salvage chemotherapy in relapsed/refractory aggressive histology non-Hodgkin's lymphoma.
    Piliotis, EG
    Mangel, J
    Buckstein, R
    Imrie, K
    Spaner, D
    Reis, M
    Foden, C
    Boudreau, A
    Richardson, P
    Richardson, J
    Berinstein, N
    BLOOD, 2003, 102 (11) : 288B - 288B
  • [49] UPDATED RESULTS OF A PHASE II TRIAL OF BENDAMUSTINE IN RELAPSED AND REFRACTORY HODGKIN LYMPHOMA
    Moskowitz, A. J.
    Hamlin, P.
    Gerecitano, J.
    Horwitz, S.
    Matasar, M.
    Noy, A.
    Palomba, M. L.
    Portlock, C.
    Straus, D.
    Graustein, T.
    Zelenetz, A.
    Moskowitz, C.
    ANNALS OF ONCOLOGY, 2011, 22 : 180 - 181
  • [50] A Phase I Study of Gemcitabine and Bendamustine in Relapsed/Refractory Hodgkin Lymphoma
    Cohen, Jonathon B.
    Wei, Lai
    Maddocks, Kami J.
    Heffner, Leonard T.
    Langston, Amelia
    Flowers, Christopher
    Devine, Steven M.
    Blum, Kristie A.
    BLOOD, 2015, 126 (23)
12345